Atlas Trials

BE Study of Fluticasone Propionate/Salmeterol Inhalation Powder in Asthma Patients

Clinical trial NCT03394989 · COMPLETED

Trial details

NCT number
NCT03394989
Sponsor
Cipla Ltd.
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Bronchial Asthma
Start date
2018-10-17
Primary completion
2019-12-03
Enrollment
1366

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.